360 related articles for article (PubMed ID: 25236784)
1. Distinguishing between driver and passenger mutations in individual cancer genomes by network enrichment analysis.
Merid SK; Goranskaya D; Alexeyenko A
BMC Bioinformatics; 2014 Sep; 15(1):308. PubMed ID: 25236784
[TBL] [Abstract][Full Text] [Related]
2. Identifying overlapping mutated driver pathways by constructing gene networks in cancer.
Wu H; Gao L; Li F; Song F; Yang X; Kasabov N
BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S3. PubMed ID: 25859819
[TBL] [Abstract][Full Text] [Related]
3. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
Zhang J; Zhang S; Wang Y; Zhang XS
BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
[TBL] [Abstract][Full Text] [Related]
4. Individualized discovery of rare cancer drivers in global network context.
Petrov I; Alexeyenko A
Elife; 2022 May; 11():. PubMed ID: 35593700
[TBL] [Abstract][Full Text] [Related]
5. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
Zhang W; Wang SL
Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
[TBL] [Abstract][Full Text] [Related]
6. De novo discovery of mutated driver pathways in cancer.
Vandin F; Upfal E; Raphael BJ
Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
[TBL] [Abstract][Full Text] [Related]
7. CanDrA: cancer-specific driver missense mutation annotation with optimized features.
Mao Y; Chen H; Liang H; Meric-Bernstam F; Mills GB; Chen K
PLoS One; 2013; 8(10):e77945. PubMed ID: 24205039
[TBL] [Abstract][Full Text] [Related]
8. Discovering potential cancer driver genes by an integrated network-based approach.
Shi K; Gao L; Wang B
Mol Biosyst; 2016 Aug; 12(9):2921-31. PubMed ID: 27426053
[TBL] [Abstract][Full Text] [Related]
9. Automated network analysis identifies core pathways in glioblastoma.
Cerami E; Demir E; Schultz N; Taylor BS; Sander C
PLoS One; 2010 Feb; 5(2):e8918. PubMed ID: 20169195
[TBL] [Abstract][Full Text] [Related]
10. QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency.
Bokhari Y; Alhareeri A; Arodz T
BMC Bioinformatics; 2020 Mar; 21(1):122. PubMed ID: 32293263
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous identification of multiple driver pathways in cancer.
Leiserson MD; Blokh D; Sharan R; Raphael BJ
PLoS Comput Biol; 2013; 9(5):e1003054. PubMed ID: 23717195
[TBL] [Abstract][Full Text] [Related]
12. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
Sintupisut N; Liu PL; Yeang CH
Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
[TBL] [Abstract][Full Text] [Related]
13. LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network.
Wei PJ; Zhang D; Xia J; Zheng CH
BMC Bioinformatics; 2016 Dec; 17(Suppl 17):467. PubMed ID: 28155630
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.
Nono AD; Chen K; Liu X
BMC Med Genomics; 2019 Jan; 12(Suppl 1):22. PubMed ID: 30704472
[TBL] [Abstract][Full Text] [Related]
15. WITER: a powerful method for estimation of cancer-driver genes using a weighted iterative regression modelling background mutation counts.
Jiang L; Zheng J; Kwan JSH; Dai S; Li C; Li MJ; Yu B; To KF; Sham PC; Zhu Y; Li M
Nucleic Acids Res; 2019 Sep; 47(16):e96. PubMed ID: 31287869
[TBL] [Abstract][Full Text] [Related]
16. OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers.
Wang T; Ruan S; Zhao X; Shi X; Teng H; Zhong J; You M; Xia K; Sun Z; Mao F
Nucleic Acids Res; 2021 Jan; 49(D1):D1289-D1301. PubMed ID: 33179738
[TBL] [Abstract][Full Text] [Related]
17. DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer.
Bashashati A; Haffari G; Ding J; Ha G; Lui K; Rosner J; Huntsman DG; Caldas C; Aparicio SA; Shah SP
Genome Biol; 2012 Dec; 13(12):R124. PubMed ID: 23383675
[TBL] [Abstract][Full Text] [Related]
18. Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.
Gu Y; Wang H; Qin Y; Zhang Y; Zhao W; Qi L; Zhang Y; Wang C; Guo Z
Mol Biosyst; 2013 Mar; 9(3):467-77. PubMed ID: 23344900
[TBL] [Abstract][Full Text] [Related]
19. Efficient methods for identifying mutated driver pathways in cancer.
Zhao J; Zhang S; Wu LY; Zhang XS
Bioinformatics; 2012 Nov; 28(22):2940-7. PubMed ID: 22982574
[TBL] [Abstract][Full Text] [Related]
20. DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.
Hua X; Xu H; Yang Y; Zhu J; Liu P; Lu Y
Am J Hum Genet; 2013 Sep; 93(3):439-51. PubMed ID: 23954162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
